As of 2026-09-30, the Relative Valuation of Antibe Therapeutics Inc (ATE.TO) is (8.47) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.30 CAD, the upside of Antibe Therapeutics Inc based on Relative Valuation is -2972.8%.
The range of the Relative Valuation is (4.22) - (12.62) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 11.6x - 36.5x | 24.0x |
| Forward P/E multiples | 11.9x - 35.6x | 23.8x |
| Fair Price | (4.22) - (12.62) | (8.47) |
| Upside | -1530.4% - -4379.2% | -2972.8% |
| Date | P/E |